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Regnase-1 and Roquin regulate inflammatory mRNAs
Takashi Mino and Osamu Takeuchi
Inflammation is mediated by proinflammatory 
cytokines such as tumor necrosis factor (TNF) and 
interleukin 6 (IL-6). Innate immune cells sense pathogen 
infection via Toll-like receptors (TLRs) and rapidly 
induced production of cytokines. The expression of 
cytokine genes is tightly regulated at both transcriptional 
and post-transcriptional levels. Whereas transcription is 
the first step in the regulation of gene expression, post-
transcriptional regulation that modifies mRNA stability 
and translation provides rapid and flexible control of 
cytokine gene and protein expression. In particular, post-
transcriptional regulation is involved in resolution of 
inflammation and prevention of unintended tissue damage 
caused by excess inflammation [1]. Post-transcriptional 
events occur in various intracellular organelles, because 
eukaryotic mRNAs are in dynamic equilibrium between 
different subcellular locations; actively translated mRNAs 
can be found in polysomes, mRNAs stalled in translation 
initiation can accumulate in stress granules (SGs), and 
mRNAs targeted for degradation or translation repression 
can accumulate in processing bodies (PBs).
The degradation of mRNA seems to be the most 
efficient determinant of deactivation of inflammation, since 
it restricts the production of proinflammatory cytokines. 
Most post-transcriptional events leading to mRNA decay 
involve the interaction of RNA with RNA-binding proteins 
(RBPs). Regulatory RBPs bind to conserved cis-elements, 
including AU-rich elements (AREs) and stem-loop (SL) 
structures in their 3′ untranslated regions (UTRs) [1], and 
induce endonucleolytic cleavage or deadenylation- and 
decapping-mediated exonucleolytic decay of mRNAs. 
Recently, it has been shown that SL structures present 
in a set of mRNAs including ICOS, OX40 and TNF 
are destabilized by Roquin [2]. Roquin harbors a ROQ 
domain and a CCCH-type zinc finger domain; a loss of 
function mutation in the Roquin ROQ domain (M199R) 
in mice (San) leads to the development of autoimmune 
disease characterized by an increase in follicular helper T 
cells due to high ICOS expression [3]. Roquin-mediated 
mRNA decay takes place in PBs or SGs by recruiting a 
CCR4-CAF1-NOT deadenylase complex that initiates 
mRNA degradation.
Regnase-1 (also known as Zc3h12a, Mcpip1) is an 
endonuclease critical for preventing a severe autoimmune 
inflammatory disease in mice by destabilizing a set 
of target mRNAs via binding to a SL structure [4-
6]. Regnase-1 harbors a PIN-like RNase domain and 
a CCCH-type zinc-finger domain and controls a set 
of genes including Il6, Il12p40 and Regnase-1 itself 
in macrophages [4]. Regnase-1 is also essential for 
suppressing aberrant activation of T cells in a cell-intrinsic 
manner, and targets a set of genes, (e.g. Icos, c-Rel, 
Ox40 and Il2) for degradation [6]. However, the target 
specificity of Regnase-1 and the molecular mechanisms 
by which Regnase-1 degrades its target mRNAs are not 
yet understood.
Editorial
Figure 1: A proposed model of mRNA degradation by Regnase-1 and Roquin.
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Our study published in Cell, demonstrates that 
although Regnase-1 and Roquin regulate an overlapping 
set of mRNAs via a common SL structure, they function 
in distinct subcellular locations: ribosome/endoplasmic 
reticulum (ER) and PBs/SGs, respectively [7]. We 
identified Regnase-1 and Roquin target mRNAs by RNA-
immunoprecipitation sequencing (RIP-Seq) and gene 
set enrichment analysis (GSEA) showed that Regnase-1 
target mRNAs were significantly biased toward high 
enrichment scores in the Roquin RIP-Seq data, indicating 
that the Regnase-1 and Roquin target mRNAs overlap 
significantly. Next, we investigated target structures 
of Regnase-1 binding mRNAs globally using high-
throughput sequencing of RNA isolated by crosslinking 
immunoprecipitation (HITS-CLIP) and found that SL 
sequences with varying stem lengths (3-7 nucleotides) 
with pyrimidine-purine-pyrimidine nucleotide tri-loops 
preferentially associate with Regnase-1. Interestingly, this 
rule is consistent with that in the reported Roquin target 
mRNAs [2]. Indeed, Regnase-1 and Roquin destabilized 
the same sets of mRNAs with a target SL sequence. Taken 
together, these results demonstrate that Regnase-1 and 
Roquin recognize overlapping target mRNAs via the same 
SL structures present in their 3′ UTRs.
Despite the presence of overlapping target mRNAs, 
Regnase-1 and Roquin are found to degrade inflammatory 
mRNAs via spatiotemporally distinct mechanisms. 
Whereas Roquin localized to SGs and PBs, Regnase-1 
localized to cytoplasm, ER and polysome, but not to PBs 
and SGs. Regnase-1 destabilized translationally active 
mRNAs and translation termination was required for 
Regnase-1-mediated mRNA decay. Furthermore, we found 
that Regnase-1 associated with UPF1, an RNA helicase 
essential for nonsense-mediated RNA decay (NMD), 
and UPF1 helicase activity was critical for Regnase-1-
mediated mRNA decay. Whereas Regnase-1 and Roquin in 
part redundantly regulate their target mRNAs, Regnase-1 
and Roquin tend to control the early and late phase of 
inflammation, respectively.
Collectively, our recent study has clearly 
demonstrated that the post-transcriptional regulation of 
inflammation is controlled by Regnase-1 and Roquin 
in a spatiotemporally distinct manner (Figure 1). It 
is interesting that the machinery used for the NMD 
quality control system are also shared with those for 
the degradation of cytokine mRNAs. Although UPF1 
is essential for Regnase-1-mediated mRNA decay, the 
molecular mechanisms how UPF1 is involved in it are 
still unclear. Because excess and prolonged production 
of cytokines leads to the onset of inflammatory diseases, 
prolonged stability of inflammatory cytokine mRNAs 
may be considered aberrant, and thus targeted by a similar 
mechanism of the quality control system. Strict control 
over the life of mRNA by RBPs is a key strategic step 
by which immune cells determine their phenotypes and 
functions, and differential regulation of Regnase-1- and 
Roquin-mediated mRNA degradation are thus necessary 
for the elaborate control of inflammation.
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